Tag: GMP Active Pharmaceutical Ingredient
Patient-ready MDMA lands in Australia for GMP standard manufacturing
Australian medicinal cannabis company Vitura Health Limited has released an update on its Cortexa Joint Venture with PharmAla Biotech after landing bulk GMP Active Pharmaceutical Ingredient (API) for MDMA (3,4-Methylenedioxy-methamphetamine) in Australia.
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
